NyxoahtoReleaseFirst Quarter 2026 Financial Results on May 12, 2026Mont-Saint-Guibert, Belgium – April 28, 2026, 10:05pm CET / 4:05pm ET – Nyxoah ...

I would log six to eight hours of sleep where I was unconscious, but I wasn't getting what is 'actual' sleep," said Orsini, ...

Southern California Pulmonary and Sleep Disorders Medical Center has announced expanded access to Inspire therapy, offering a ...

Explore the best Apple Watch Ultra 3 alternatives, including high-performance models from Samsung, Garmin, and Huawei ...

Incline Sleep has announced the release of a range of adjustable bed solutions built around incline bed therapy, offering ...

TheFly reported on April 15 that Truist Financial reduced its price target for INSP from $70 to $64 while maintaining a Hold ...

A better night’s sleep is within reach for more patients in Southeast Georgia, thanks to innovative care and a ...

National leader in jaw surgery expanding practice to offer custom treatment plans for patients with Obstructive Sleep ...

With appropriate introduction of oral appliance therapy, more patients are seeing success in navigating sleep disorders and other comorbidities.

(NYSE:INSP) is among the most undervalued stocks to invest in. TheFly reported on April 15 that Truist Financial reduced its ...

LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.

A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an implanted stimulation therapy targeting specific sectors of nerves in the ...